January 27, 2026January 27, 2026 Shares of Wockhardt Ltd are trading flat after touching a day’s high of Rs 1,411.90 on 27th January. This comes despite the firm announcing that its antibiotic Foviscu successfully met the primary endpoint in a phase 3 clinical trial involving patients with complicated urinary…
Wockhardt shares rebounded 4% to Rs 1,388 in Friday’s trading session, recovering after falling 5% each day for two straight sessions. Earlier in the week, on December 1, 2025, the stock had surged 19% following a major regulatory development: the US Food and Drug Administration (FDA) formally accepted Wockhardt’s New Drug Application (NDA) for Zaynich,…
July 28, 2025July 28, 2025 Shares of Wockhardt Ltd surged 5% to touch a day’s high of Rs 1,775 on 28th July, after the company stated a medical case where its novel antibiotic Zaynich was used to treat a critically ill US liver transplant patient…